Similar Articles

Peripheral and Cortical Silent Period in Parkinson's Disease and Effects of L-DOPA

Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA

Issue: 1998, Volume 4 - Issue 3-4
0 167

Movement Related Cortical Potentials and L-DOPA in Parkinson 's Disease

Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA

Issue: 1998, Volume 4 - Issue 3-4
0 166

H-Reflex Recovery Ratios for Alfa Motor Neuron Excitability in Parkinson's Disease

Ayhan ÖZTÜRK, Hilmi UYSAL

Issue: 1998, Volume 4 - Issue 3-4
0 143

Subacute Myleo-Optic Neuropathy- Case Report

Egemen VARDARLI, Gürbüz GÜMÜŞDİŞ, Sevgi TAVUS

Issue: 1998, Volume 4 - Issue 3-4
0 141

Therapentic Advances In Multiple Sclerosis

Egemen İDİMAN

Issue: 1998, Volume 4 - Issue 1-2
0 140

P300 and P300 Topographic Mapping in Parkinson's Disease

Raif ÇAKMUR, Fethi İDİMAN, Barış BAKLAN, Birsen KESKİN, Görsev YENER, Şakir FADILOĞLU

Issue: 1995, Volume 1 - Issue 4
0 165

Moclobemide Therapy in Chronic Tension Type Headache: Clinical and Neurophysiological (P300) Follow-up.

Sibel ÖZKAYNAK, Zülküf ÖNAL, Berrin AKTEKİN, Sevin BALKAN, Uğur KAHVECİOĞLU, Korkut YALTKAYA

Issue: 1995, Volume 1 - Issue 3
0 143

THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS

Bülent ELİBOL

Issue: 1995, Volume 1 - Issue 1
0 171

Intravenous Immunoglobulin Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Sevim ERDEM, Kubilay VARLI, Gülay NURLU, Okay SARIBAŞ, Ersin TAN

Issue: 1995, Volume 1 - Issue 1
0 146

Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies

Muhteşem GEDİZOĞLU

Issue: 2009, Volume 15 - Supplement 3
0 201